NEW YORK: New recommendation that men around 75 must not be screened for prostate tumor won’t overwhelm the long-lasting argument over the pros of the blood examination for the disorder, according to cancer specialists.

“This encourages the discussion, I suppose,” said by Dr. Charles Ryan, a prostate cancer expert at the University of California, San Francisco.

A lot of specialists are conducting new researches regarding the prostate cancer that might show more evidences of all aging groups of prostate tumor.

The U.S. Preventive Services Task Force, a committee of specialists who backup the national health care, published its description on Monday focused on a review of past research. The researchers detected that screening could found a number of victims of prostate cancer, but the pros of surgery in men over 75 “are petite to none.”